Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries

被引:12
作者
Zhong, Cheng [1 ,2 ,3 ]
Xu, Minze [1 ,2 ,3 ]
Boral, Senguel [2 ,3 ,4 ]
Summer, Holger [5 ]
Lichtenberger, Falk-Bach [1 ,2 ,3 ]
Erdogan, Cem [1 ,2 ,3 ]
Gollasch, Maik [6 ,7 ]
Golz, Stefan [5 ]
Persson, Pontus B. [1 ,2 ,3 ]
Schleifenbaum, Johanna [1 ,2 ,3 ]
Patzak, Andreas [1 ,2 ,3 ]
Khedkar, Pratik H. [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany
[2] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany
[3] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany
[4] Charite Univ Med Berlin, Inst Pathol, Charitepl 1, D-10117 Berlin, Germany
[5] Bayer AG, Res & Dev, D-42113 Wuppertal, Germany
[6] Charite Univ Med Berlin, Expt & Clin Res Ctr ECRC, D-13125 Berlin, Germany
[7] Univ Greifswald, Dept Internal & Geriatr Med, Geriatr Med, D-17475 Greifswald, Germany
关键词
aging; mesenteric artery; nitric oxide; soluble guanylyl cyclase; soluble guanylyl cyclase activator; NITRIC-OXIDE SYNTHASE; PHOSPHODIESTERASE 3A EXPRESSION; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; CORONARY-ARTERY; HYPERTENSION; VASODILATION; STRESS; VASCULATURE; ACTIVATION;
D O I
10.3390/ijms222111412
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelial dysfunction (ED) comes with age, even without overt vessel damage such as that which occurs in atherosclerosis and diabetic vasculopathy. We hypothesized that aging would affect the downstream signalling of the endothelial nitric oxide (NO) system in the vascular smooth muscle (VSM). With this in mind, resistance mesenteric arteries were isolated from 13-week (juvenile) and 40-week-old (aged) mice and tested under isometric conditions using wire myography. Acetylcholine (ACh)-induced relaxation was reduced in aged as compared to juvenile vessels. Pretreatment with L-NAME, which inhibits nitrix oxide synthases (NOS), decreased ACh-mediated vasorelaxation, whereby differences in vasorelaxation between groups disappeared. Endothelium-independent vasorelaxation by the NO donor sodium nitroprusside (SNP) was similar in both groups; however, SNP bolus application (10(-6) mol L-1) as well as soluble guanylyl cyclase (sGC) activation by runcaciguat (10(-6) mol L-1) caused faster responses in juvenile vessels. This was accompanied by higher cGMP concentrations and a stronger response to the PDE5 inhibitor sildenafil in juvenile vessels. Mesenteric arteries and aortas did not reveal apparent histological differences between groups (van Gieson staining). The mRNA expression of the alpha 1 and alpha 2 subunits of sGC was lower in aged animals, as was PDE5 mRNA expression. In conclusion, vasorelaxation is compromised at an early age in mice even in the absence of histopathological alterations. Vascular smooth muscle sGC is a key element in aged vessel dysfunction.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase
    Klöss, S
    Bouloumié, A
    Mülsch, A
    HYPERTENSION, 2000, 35 (01) : 43 - 47
  • [32] Linalool elicits vasorelaxation of mouse aortae through activation of guanylyl cyclase and K+ channels
    Kang, Purum
    Seol, Geun Hee
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2015, 67 (05) : 714 - 719
  • [33] Nucleotidyl Cyclase Activity of Soluble Guanylyl Cyclase α1β1
    Beste, Kerstin Y.
    Burhenne, Heike
    Kaever, Volkhard
    Stasch, Johannes-Peter
    Seifert, Roland
    BIOCHEMISTRY, 2012, 51 (01) : 194 - 204
  • [34] Restoring Soluble Guanylyl Cyclase Expression and Function Blocks the Aggressive Course of Glioma
    Zhu, Haifeng
    Li, Jessica Tao
    Zheng, Fang
    Martin, Emil
    Kots, Alexander Y.
    Krumenacker, Joshua S.
    Choi, Byung-Kwon
    McCutcheon, Ian E.
    Weisbrodt, Norman
    Boegler, Oliver
    Murad, Ferid
    Bian, Ka
    MOLECULAR PHARMACOLOGY, 2011, 80 (06) : 1076 - 1084
  • [35] Localization of soluble guanylyl cyclase α-subunit in identified insect neurons
    Elphick, MR
    Jones, IW
    BRAIN RESEARCH, 1998, 800 (01) : 174 - 179
  • [36] Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone
    Charlotte Detremmerie
    Paul M. Vanhoutte
    Susan Leung
    ActaPharmaceuticaSinicaB, 2017, 7 (04) : 401 - 408
  • [37] Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase
    Olesen, SP
    Drejer, J
    Axelsson, O
    Moldt, P
    Bang, L
    Nielsen-Kudsk, JE
    Busse, R
    Mülsch, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (02) : 299 - 309
  • [38] Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species
    Gerassimou, C.
    Kotanidou, A.
    Zhou, Z.
    Simoes, D. C. M.
    Roussos, C.
    Papapetropoulos, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (08) : 1084 - 1091
  • [39] Soluble guanylyl cyclase: more secrets revealed
    Pyriochou, A
    Papapetropoulos, A
    CELLULAR SIGNALLING, 2005, 17 (04) : 407 - 413
  • [40] Disruption of retinogeniculate pattern formation by inhibition of soluble guanylyl cyclase
    Leamey, CA
    Ho-Pao, CL
    Sur, M
    JOURNAL OF NEUROSCIENCE, 2001, 21 (11) : 3871 - 3880